Clinical Trials Without Clinical Sites

被引:16
|
作者
Cummings, Steven R. [1 ,2 ]
机构
[1] Calif Pacific Med Ctr, San Francisco Coordinating Ctr, Res Inst, 550 16th St,2nd Floor,Mission Hall,POB 0560, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
关键词
INFORMED-CONSENT; PARTICIPANTS;
D O I
10.1001/jamainternmed.2020.9223
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical trials conducted at clinical sites are limited to enrolling people who live nearby and are able to attend visits at clinics. Some types of clinical trials can be performed without clinical sites, which enables people to participate regardless of proximity to a clinical site or limitations that make visits difficult. Trials at clinical sites involve face-to-face relationships with in-person collection of informed consent, examinations, data, and specimens. In contrast, without clinical sites, informed consent and data are obtained online, limited examinations can be performed by telemedicine or visiting research nurses, biospecimens can be collected by visiting nurses or local laboratories, and treatments can be sent to homes or administered by nurses in participants' homes. Trials without clinical sites require internet access and must adapt to the lack of face-to-face interactions with study staff, with communication conducted by email, telephone, or video. Many trials cannot be performed entirely without clinical sites because they require examinations, tests, or treatments that must be given at a clinical site. However, some of the methods required for trials without sites, such as online data collection, follow-up visits by telemedicine or research nurses, and delivery of treatments to home, could reduce the need for visits to clinical sites and reduce the burden of participating in a clinical trial. When feasible, conducting clinical trials without clinical sites has the potential to expand participation and the generalizability of their results.
引用
收藏
页码:680 / 684
页数:5
相关论文
共 50 条
  • [31] Comparison of Academic and Nonacademic Sites in Multi-Center Clinical Trials
    Dording, Christina M.
    Dalton, Elizabeth D.
    Pencina, Michael J.
    Fava, Maurizio
    Mischoulon, David
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (01) : 65 - 68
  • [32] ASSESSMENT OF FIELD SITES FOR CLINICAL TRIALS OF A NEW MALARIA VACCINE IN AFRICA
    Laurens, Matthew B.
    Ogutu, Bernhards R.
    Lemiale, Laurence
    Kronmann, Karl C.
    Rosendorf, Linda
    Plowe, Christopher V.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (05): : 309 - 310
  • [33] Clinical trials
    Palmer, N
    Kay, E
    [J]. BRITISH DENTAL JOURNAL, 2005, 198 (06) : 350 - 350
  • [34] Clinical trials
    不详
    [J]. BIOTECHNOLOGY LAW REPORT, 1999, 18 (02) : 174 - 176
  • [35] CLINICAL TRIALS
    DOLL, WRS
    [J]. BIOCHEMICAL PHARMACOLOGY, 1963, 12 : 137 - &
  • [36] Clinical trials
    [J]. Genetic Engineering and Biotechnology News, 2013, 33 (21): : 44 - 45
  • [37] Clinical trials
    Michael Francisco
    [J]. Nature Biotechnology, 1999, 17 : 202 - 202
  • [38] Clinical trials
    Alsner, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S291 - S292
  • [39] Clinical trials
    BlichertToft, M
    Mouridsen, H
    Andersen, KW
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1996, 12 (01): : 32 - 38
  • [40] CLINICAL TRIALS
    MAGGS, R
    [J]. BRITISH MEDICAL JOURNAL, 1966, 2 (5514): : 645 - &